Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 172Breast Neoplasms 24Neoplasms 13Leiomyoma 11Polycystic Ovary Syndrome 5Prostate Adenocarcinoma 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Adenocarcinoma 3Salivary Gland Neoplasms 2Rare Diseases 2Myofibroma 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Breast Neoplasms, Male 2Uveal Melanoma 1Uterine Neoplasms 1Urogenital Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasm Duct 1Respiratory Tract Diseases 1Recurrence 1Puberty, Precocious 1

Interventions

Inositol 2relacorilant 1pembrolizumab 1maltodextrin 1Pioglitazone 1Metformin 1Liraglutide 1Leuprolide 1Inulin 1Estrogens 1Continuous Positive Airway Pressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Glucose Intolerance × Leuprolide × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡